Provides Patent Protection in Europe Through at Least December 2040
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Seeking Alpha / 3 hours ago 1 Views
Seeking Alpha / 3 hours ago 1 Views
Provides Patent Protection in Europe Through at Least December 2040
Comments